ITPD20050242A1 - Bioconiugati antitumorali dell'acido ialuronico o dei suoi derivati, ottenibili per coniugazione chimica diretta o indiretta, e loro impiego in campo farmaceutico - Google Patents

Bioconiugati antitumorali dell'acido ialuronico o dei suoi derivati, ottenibili per coniugazione chimica diretta o indiretta, e loro impiego in campo farmaceutico

Info

Publication number
ITPD20050242A1
ITPD20050242A1 IT000242A ITPD20050242A ITPD20050242A1 IT PD20050242 A1 ITPD20050242 A1 IT PD20050242A1 IT 000242 A IT000242 A IT 000242A IT PD20050242 A ITPD20050242 A IT PD20050242A IT PD20050242 A1 ITPD20050242 A1 IT PD20050242A1
Authority
IT
Italy
Prior art keywords
bioconiugati
antitumorali
obtainable
derivatives
direct
Prior art date
Application number
IT000242A
Other languages
English (en)
Inventor
Fabio Bettella
Davide Renier
Original Assignee
Fidia Farmaceutici
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Farmaceutici filed Critical Fidia Farmaceutici
Priority to IT000242A priority Critical patent/ITPD20050242A1/it
Priority to DK11159649.0T priority patent/DK2540319T3/en
Priority to SI200632189T priority patent/SI2537533T1/sl
Priority to KR1020087004522A priority patent/KR101614157B1/ko
Priority to PL11159649T priority patent/PL2540319T3/pl
Priority to RU2008102878/05A priority patent/RU2411958C2/ru
Priority to EP11159649.0A priority patent/EP2540319B1/en
Priority to PL06762981T priority patent/PL1909843T3/pl
Priority to CN200680034187.0A priority patent/CN101267840B/zh
Priority to CA2616957A priority patent/CA2616957C/en
Priority to EP11159664.9A priority patent/EP2548582B1/en
Priority to NZ565504A priority patent/NZ565504A/en
Priority to PCT/EP2006/007717 priority patent/WO2007014784A2/en
Priority to BRPI0614536-1A priority patent/BRPI0614536A2/pt
Priority to US11/989,716 priority patent/US9687558B2/en
Priority to ES11159664.9T priority patent/ES2692619T3/es
Priority to ES11159649.0T priority patent/ES2633291T3/es
Priority to AU2006274992A priority patent/AU2006274992B2/en
Priority to EP06762981.6A priority patent/EP1909843B1/en
Priority to JP2008524445A priority patent/JP5457672B2/ja
Priority to ES06762981.6T priority patent/ES2596877T3/es
Priority to SI200632187T priority patent/SI2540319T1/sl
Priority to PL11159629T priority patent/PL2537533T3/pl
Priority to EP11159629.2A priority patent/EP2537533B1/en
Priority to ES11159629.2T priority patent/ES2633290T3/es
Priority to SI200632120A priority patent/SI1909843T1/sl
Priority to DK11159629.2T priority patent/DK2537533T3/da
Priority to CN201210568694XA priority patent/CN103041402A/zh
Publication of ITPD20050242A1 publication Critical patent/ITPD20050242A1/it
Priority to IL189078A priority patent/IL189078A0/en
Priority to NO20080564A priority patent/NO20080564L/no
Priority to HK08108481.1A priority patent/HK1118011A1/zh
Priority to JP2013212756A priority patent/JP2014001249A/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
IT000242A 2005-08-03 2005-08-03 Bioconiugati antitumorali dell'acido ialuronico o dei suoi derivati, ottenibili per coniugazione chimica diretta o indiretta, e loro impiego in campo farmaceutico ITPD20050242A1 (it)

Priority Applications (32)

Application Number Priority Date Filing Date Title
IT000242A ITPD20050242A1 (it) 2005-08-03 2005-08-03 Bioconiugati antitumorali dell'acido ialuronico o dei suoi derivati, ottenibili per coniugazione chimica diretta o indiretta, e loro impiego in campo farmaceutico
ES11159664.9T ES2692619T3 (es) 2005-08-03 2006-08-02 Bioconjugados antitumorales de ácido hialurónico o sus derivados obtenidos por conjugación química indirecta
EP11159629.2A EP2537533B1 (en) 2005-08-03 2006-08-02 Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation
KR1020087004522A KR101614157B1 (ko) 2005-08-03 2006-08-02 간접적인 화학적 공액에 의해 수득되는, 히알루론산 또는이의 유도체의 항암 바이오컨쥬게이트
PL11159649T PL2540319T3 (pl) 2005-08-03 2006-08-02 Przeciwnowotworowe biokoniugaty kwasu hialuronowego lub jego pochodne otrzymane przez pośrednie sprzęganie chemiczne
RU2008102878/05A RU2411958C2 (ru) 2005-08-03 2006-08-02 Противоопухолевые биоконъюгаты гиалуроновой кислоты или ее производных, полученные непрямой химической конъюгацией
EP11159649.0A EP2540319B1 (en) 2005-08-03 2006-08-02 Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation
AU2006274992A AU2006274992B2 (en) 2005-08-03 2006-08-02 Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation
CN200680034187.0A CN101267840B (zh) 2005-08-03 2006-08-02 通过间接化学轭合获得的透明质酸或其衍生物的抗肿瘤生物轭合物
CA2616957A CA2616957C (en) 2005-08-03 2006-08-02 Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation
EP11159664.9A EP2548582B1 (en) 2005-08-03 2006-08-02 Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation
NZ565504A NZ565504A (en) 2005-08-03 2006-08-02 Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation
PCT/EP2006/007717 WO2007014784A2 (en) 2005-08-03 2006-08-02 Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation
BRPI0614536-1A BRPI0614536A2 (pt) 2005-08-03 2006-08-02 conjugados quìmico-farmacêuticos de ácido hialurÈnico e/ou seus derivados, composições farmacêuticas, biomateriais tridimensionais, uso dos conjugados quìmicos-farmacêuticos, e, processo para a preparação dos conjugados quìmico-farmacêuticos
US11/989,716 US9687558B2 (en) 2005-08-03 2006-08-02 Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation, and their use in the pharmaceutical field
DK11159649.0T DK2540319T3 (en) 2005-08-03 2006-08-02 Anti-tumor bioconjugates of hyaluronic acid or derivatives thereof obtained by indirect chemical conjugation
ES11159649.0T ES2633291T3 (es) 2005-08-03 2006-08-02 Bioconjugados antitumorales de ácido hialurónico o sus derivados obtenidos por conjugación química indirecta
PL06762981T PL1909843T3 (pl) 2005-08-03 2006-08-02 Przeciwnowotworowe biokoniugaty kwasu hialuronowego lub jego pochodne otrzymane przez pośrednie sprzęganie chemiczne i ich zastosowanie w dziedzinie farmacji
EP06762981.6A EP1909843B1 (en) 2005-08-03 2006-08-02 Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation, and their use in the pharmaceutical field
JP2008524445A JP5457672B2 (ja) 2005-08-03 2006-08-02 間接的な化学的複合体形成によって得られるヒアルロン酸又はその誘導体の抗腫瘍性バイオ複合体、及び医薬分野におけるそれらの使用
ES06762981.6T ES2596877T3 (es) 2005-08-03 2006-08-02 Bioconjugados antitumorales de ácido hialurónico o sus derivados obtenidos por conjugación química indirecta, y su uso en el campo farmacéutico
SI200632187T SI2540319T1 (sl) 2005-08-03 2006-08-02 Protitumorski biokonjugati hialuronske kisline ali njenih derivatov, dobljeni z indirektno kemijsko konjugacijo
PL11159629T PL2537533T3 (pl) 2005-08-03 2006-08-02 Przeciwnowotworowe biokoniugaty kwasu hialuronowego lub jego pochodne otrzymane przez pośrednie sprzęganie chemiczne
SI200632189T SI2537533T1 (sl) 2005-08-03 2006-08-02 Protitumorski biokonjugati hialuronske kisline ali njenih derivatov, dobljeni z indirektno kemijsko konjugacijo
ES11159629.2T ES2633290T3 (es) 2005-08-03 2006-08-02 Bioconjugados antitumorales de ácido hialurónico o sus derivados obtenidos por conjugación química indirecta
SI200632120A SI1909843T1 (sl) 2005-08-03 2006-08-02 Protitumorski biokonjugati hialuronske kisline ali njenih derivatov, dobljeni z indirektno kemijsko konjugacijo, in njihova uporaba na farmacevtskem področju
DK11159629.2T DK2537533T3 (da) 2005-08-03 2006-08-02 Antitumor-biokonjugater af hyaluronsyre eller derivater deraf opnået ved indirekte kemisk konjugation
CN201210568694XA CN103041402A (zh) 2005-08-03 2006-08-02 通过间接化学轭合获得的透明质酸或其衍生物的抗肿瘤生物轭合物
IL189078A IL189078A0 (en) 2005-08-03 2008-01-28 Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation
NO20080564A NO20080564L (no) 2005-08-03 2008-01-30 Antitumorale biokonjugater av hyaluronsyre eller dens derivater oppnadd ved indirekte kjemisk konjugering, og deres anvendelse innen det farmasoytiske omradet
HK08108481.1A HK1118011A1 (zh) 2005-08-03 2008-07-31 透明質酸的抗腫瘤生物結合物或以化學接合方法間接地取得的衍生物，以及其製藥用途
JP2013212756A JP2014001249A (ja) 2005-08-03 2013-10-10 間接的な化学的複合体形成によって得られるヒアルロン酸又はその誘導体の抗腫瘍性バイオ複合体、及び医薬分野におけるそれらの使用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000242A ITPD20050242A1 (it) 2005-08-03 2005-08-03 Bioconiugati antitumorali dell'acido ialuronico o dei suoi derivati, ottenibili per coniugazione chimica diretta o indiretta, e loro impiego in campo farmaceutico

Publications (1)

Publication Number Publication Date
ITPD20050242A1 true ITPD20050242A1 (it) 2007-02-04

Family

ID=37038336

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000242A ITPD20050242A1 (it) 2005-08-03 2005-08-03 Bioconiugati antitumorali dell'acido ialuronico o dei suoi derivati, ottenibili per coniugazione chimica diretta o indiretta, e loro impiego in campo farmaceutico

Country Status (19)

Country Link
US (1) US9687558B2 (it)
EP (4) EP2537533B1 (it)
JP (2) JP5457672B2 (it)
KR (1) KR101614157B1 (it)
CN (2) CN103041402A (it)
AU (1) AU2006274992B2 (it)
BR (1) BRPI0614536A2 (it)
CA (1) CA2616957C (it)
DK (2) DK2537533T3 (it)
ES (4) ES2633291T3 (it)
HK (1) HK1118011A1 (it)
IL (1) IL189078A0 (it)
IT (1) ITPD20050242A1 (it)
NO (1) NO20080564L (it)
NZ (1) NZ565504A (it)
PL (3) PL1909843T3 (it)
RU (1) RU2411958C2 (it)
SI (3) SI2537533T1 (it)
WO (1) WO2007014784A2 (it)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006266741B2 (en) * 2005-07-06 2011-09-01 Seikagaku Corporation Drug-introduced photo-crosslinked hyaluronic acid derived gel
ITMI20071267A1 (it) * 2007-06-22 2008-12-23 Fidia Farmaceutici Uso di coniugati dell'acido ialuronico nel trattamento locale di malattie cutanee iperproliferative
IE20070900A1 (en) * 2007-12-12 2009-06-24 Eurand Pharmaceuticals Ltd New anticancer conjugates
US20120100218A1 (en) * 2008-01-30 2012-04-26 Laird Forrest Intralymphatic Chemotherapy Drug Carriers
CN101965201B (zh) * 2008-01-30 2013-10-23 堪萨斯大学 ***内化疗药物载体
IT1391006B1 (it) * 2008-10-08 2011-10-27 Fidia Farmaceutici Uso terapeutico di nuove preparazioni farmaceutiche contenenti farmaci antitumorali legati all'acido ialuronico nel trattamento delle neoplasie
BRPI0910570A2 (pt) 2008-04-22 2015-09-22 Fidia Farmaceutici uso de bioconjugados, e, formulações farmacêuticas
KR20110032561A (ko) * 2009-09-23 2011-03-30 포항공과대학교 산학협력단 약물 전달체의 표적 특이성 조절 방법, 표적 특이적 약물 전달체, 및 표적-비특이적 약효 장기 지속성 약물 전달체
CN102399295B (zh) 2010-09-09 2013-11-06 常州百瑞吉生物医药有限公司 低巯基化改性度生物相容高分子巯基化衍生物及其交联材料和用途
CA2910325A1 (en) * 2013-04-25 2014-10-30 Aluron Biopharma Inc. Crosslinked hyaluronic acid compositions
WO2015005459A1 (ja) * 2013-07-10 2015-01-15 生化学工業株式会社 呼吸器投与用の医薬組成物
CZ305153B6 (cs) * 2014-03-11 2015-05-20 Contipro Biotech S.R.O. Konjugáty oligomeru kyseliny hyaluronové nebo její soli, způsob jejich přípravy a použití
CN104497167B (zh) * 2014-11-24 2017-05-17 山东省药学科学院 透明质酸衍生物及其治疗药物
CN105727305B (zh) * 2016-02-24 2018-09-07 温州医科大学 一种Legumain响应释放阿霉素缓释纳米制剂及制备方法与作为制备载体药物的应用
CN108912245B (zh) * 2018-07-13 2020-04-28 吉林大学 一种具有靶向性和抗炎活性的氟化透明质酸衍生物及其制备方法和应用
WO2020067507A1 (ja) * 2018-09-28 2020-04-02 生化学工業株式会社 第１級アミン化合物又は第２級アミン化合物－酸性多糖コンジュゲートとその製造方法
CA3170553A1 (en) * 2020-06-08 2021-12-16 Hua-Yang Lin Uses of hyaluronan-nimesulide conjugates in the treatment of acute pulmonary inflammation
CN111892668B (zh) * 2020-07-03 2022-07-12 广东工业大学 一种化合物及其制备方法、荧光探针和抗肿瘤药物
CN112089690A (zh) * 2020-08-31 2020-12-18 厦门大学 一种透明质酸化青蒿琥酯、其纳米胶束制剂及其制备方法和用途
CN112608397B (zh) * 2020-11-30 2021-12-28 西安交通大学 一种铂类抗肿瘤药物-多糖聚合物纳米前药及制备方法和应用
WO2022266472A1 (en) * 2021-06-18 2022-12-22 Aihol Corporation Uses of hyaluronan conjugate

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH666897A5 (fr) 1983-10-11 1988-08-31 Fidia Spa Fractions d'acide hyaluronique non inflammatoire, procedes et compositions pharmaceutiques.
US4851521A (en) 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
IT1219587B (it) 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
EP0506976B1 (en) * 1990-10-18 1997-04-09 Shiseido Company Limited Combination of hyaluronic acid with medicinal ingredient and production thereof
IT1247175B (it) 1991-04-19 1994-12-12 Fidia Spa Procedimento per la purificazione di acido ialuronico e frazione di acido ialuronico puro per uso oftalmico.
AU4406793A (en) * 1992-06-04 1993-12-30 Clover Consolidated, Limited Water-soluble polymeric carriers for drug delivery
DE69425464T2 (de) 1993-02-26 2001-05-23 Drug Delivery System Inst Ltd Polysaccharidderivat und wirkstoffträger
US5616568A (en) * 1993-11-30 1997-04-01 The Research Foundation Of State University Of New York Functionalized derivatives of hyaluronic acid
ITPD940054A1 (it) 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
CA2192725C (en) 1995-12-28 2004-04-20 Kenji Tsujihara Camptothecin derivatives
JP3737518B2 (ja) 1996-03-12 2006-01-18 ピージー−ティーエックスエル カンパニー， エル．ピー． 水溶性パクリタキセルプロドラッグ
TW409058B (en) 1996-06-06 2000-10-21 Daiichi Seiyaku Co Method for preparation of a drug complex
ITPD980169A1 (it) 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
CZ20023330A3 (cs) * 2000-03-17 2003-02-12 Cell Therapeutics, Inc. Konjugáty kamptotecinu a polyglutamové kyseliny a způsoby přípravy
GB0012718D0 (en) * 2000-05-24 2000-07-19 Angeletti P Ist Richerche Bio Conjugates of aminodrugs
IT1317359B1 (it) 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl Polisaccaridi percarbossilati, quali l'acido ialuronico, processo perla loro preparazione e loro impiego in campo farmaceutico e
IT1317358B1 (it) 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl Derivati cross-linkati dell'acido ialuronico.
EP1389090A2 (en) * 2001-04-26 2004-02-18 Board of Regents, The University of Texas System Diagnostic imaging compositions, their methods of synthesis and use
CA2445985A1 (en) 2001-05-04 2002-11-14 University Of Utah Research Foundation Hyaluronic acid containing bioconjugates: targeted delivery of anti-cancer drugs to cancer cells
US7034127B2 (en) * 2002-07-02 2006-04-25 Genzyme Corporation Hydrophilic biopolymer-drug conjugates, their preparation and use
ITPD20020271A1 (it) * 2002-10-18 2004-04-19 Fidia Farmaceutici Composti chimico-farmaceutici costituiti da derivati dei taxani legati covalentemente all'acido ialuronico o ai suoi derivati.

Also Published As

Publication number Publication date
PL2540319T3 (pl) 2017-10-31
EP2548582B1 (en) 2018-09-19
AU2006274992A1 (en) 2007-02-08
ES2596877T3 (es) 2017-01-12
JP5457672B2 (ja) 2014-04-02
WO2007014784A2 (en) 2007-02-08
PL2537533T3 (pl) 2017-10-31
EP2537533B1 (en) 2017-05-17
ES2633291T3 (es) 2017-09-20
AU2006274992B2 (en) 2012-03-08
ES2692619T3 (es) 2018-12-04
EP1909843B1 (en) 2016-09-21
JP2009503010A (ja) 2009-01-29
DK2540319T3 (en) 2017-08-21
BRPI0614536A2 (pt) 2012-11-27
EP2537533A3 (en) 2013-01-09
CN101267840B (zh) 2015-07-08
US20080292703A1 (en) 2008-11-27
NZ565504A (en) 2011-02-25
SI2537533T1 (sl) 2017-10-30
JP2014001249A (ja) 2014-01-09
KR101614157B1 (ko) 2016-04-20
CN103041402A (zh) 2013-04-17
KR20080032235A (ko) 2008-04-14
PL1909843T3 (pl) 2017-03-31
NO20080564L (no) 2008-05-05
CA2616957C (en) 2016-04-26
SI1909843T1 (sl) 2017-01-31
HK1118011A1 (zh) 2009-01-30
EP2548582A1 (en) 2013-01-23
IL189078A0 (en) 2008-08-07
DK2537533T3 (da) 2017-08-21
US9687558B2 (en) 2017-06-27
WO2007014784A3 (en) 2007-05-18
EP2537533A2 (en) 2012-12-26
CA2616957A1 (en) 2007-02-08
RU2411958C2 (ru) 2011-02-20
EP1909843A2 (en) 2008-04-16
EP2540319B1 (en) 2017-05-10
WO2007014784A9 (en) 2007-07-12
EP2540319A1 (en) 2013-01-02
ES2633290T3 (es) 2017-09-20
CN101267840A (zh) 2008-09-17
SI2540319T1 (sl) 2017-08-31
RU2008102878A (ru) 2009-09-10

Similar Documents

Publication Publication Date Title
ITPD20050242A1 (it) Bioconiugati antitumorali dell'acido ialuronico o dei suoi derivati, ottenibili per coniugazione chimica diretta o indiretta, e loro impiego in campo farmaceutico
ITMI20072416A1 (it) Derivati polisaccaridici dell'acido lipoico, loro preparazione ed uso come dermocosmetici e presidi medicali
IT1362675B (it) N-idrossiammidi -sostituiti con gruppi triciclici come inibitori dell'istone deacelitasi,loro preparazione ed impiego in formulazioni farmaceutiche
ATE517621T1 (de) Verwendung von ampk-aktivierenden imidazol- derivaten, herstellungsverfahren dafür und diese enthaltende pharmazeutische zusammensetzungen
MY147994A (en) Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors
NO2014028I2 (no) Glukopyranosyl-substituerte benzenderivater, fremgangsmåte for fremstilling av disse, fysiologisk akseptable salter av slike forbindelser, medikamenter inneholdende slike forbindelser og kombinasjoner med andre aktive substanser samt deresanvendelse for fremstilling av medikamenter for behandling av sykdom
IL188494A0 (en) Novel 2,4-dianlinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as ikk inhibitors
WO2007038459A3 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
WO2008087367A3 (fr) Derives de (phenylthiazolyl)-phenyl-propan-1-one et de (phenyloxazodyl)-phenyl-propan-1-one substitues, preparations et utilisations
SMT201300080B (it) Derivati di carbammati di alchiltiazoli, loro preparazione e loro utilizzo come inibitori dell'enzima faah
WO2008087365A3 (fr) Derives de 1,3-diphenylpropane substitues, preparations et utilisations
ITPD20050056A1 (it) Derivati ammidici del'acido ialuronico in osteoartrosi
ITMI20061672A1 (it) Formulazioni di acido acetilsalicilico o suoi derivati in capsule molli,esibenti elevata stabilita'
UA94603C2 (ru) Производные тетрагидронафталина, способ их получения и их применения в качестве ингибиторов воспаления
BRPI0818267A2 (pt) Novos derivados de 1,3-dihidro-5-isobenzofuranocarbonitrila e composição farmacêutica dos mesmos para o tratamento de ejaculação precoce
ITPD20050168A1 (it) Formulazioni di acido lipoico ed acido ialuronico e o suoi derivati e loro impiego in campo farmaceutico e cosmetico
IL194880A (en) Aminazole amine derivatives, their use in the treatment of diseases and pharmaceuticals containing them
CY1109537T1 (el) Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης
ITFI20050041A1 (it) Idrossammati come inibitori dell'istone deacelitasi, loro preparazione e formulazioni farmaceutiche che li contengono
ATE531703T1 (de) Benzochromenderivate
ITRM20070038A1 (it) Forme solubili di complessi di inclusione di inibitori dell istone deacetilasi e ciclodestrine loro processi di preparazione e impieghi in campo farmaceutico
CL2007000789A1 (es) Compuestos derivados de malonamida, inhibidores de la gamma-secretasa; proceso de preparacion; composicion farmaceutica; y su uso en el tratamiento de la enfermedad de alzheimer.
CO6290689A2 (es) Derivados de 1,2,3,4-tetrahidropirrolo[1,2]pirazina-6-carboxamidas y de 2,3,4,5-tetrahidropirrol[1,2][1,4]-diazepina -7-carboxamidas su preparacion y su aplicacion en terapeutica
SMT201400097B (it) Derivati di 2 piridin-2-il-pirazol-3(2H)-one, loropreparazione e loro applicazione in campo terapeu tico come attivatori di hif
EP2196463A4 (en) PREPARATION OF 5,6-DIMETHYLXANTHONE-4-ACETIC ACID, DERIVATIVES DERIVATED THEREOF AND PHARMACEUTICAL FORMULATIONS THEREOF